Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
http://img.marketwire.com/rss/mwPBES.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  announces  cannabis  clinical  company  financial results  marketwired nov  marketwired  nov  november  otcqb  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies



Marketwired - Equipment and Supplies



Last Build Date: Fri, 17 Nov 2017 12:34:27 EST

Copyright: Copyright: (C) Marketwired
 



Angle PLC: Holding(s) in Company

Fri, 17 Nov 2017 12:03:26 EST

GUILDFORD, SURREY--(Marketwired - Nov 17, 2017) -  Angle PLC (AIM: AGL) (OTCQX: ANPCY)




CFN Media Exclusive Onsite CEO Interview with Lifestyle Delivery Systems: Up and Running in a $5 Billion Market

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article covering Lifestyle Delivery Systems Inc. (CSE: LDS) (CNSX: LDS) (LDS.CN) (OTCQB: LDSYF), its new state of the art facility in Adelanto, California, and the potential for the company as California implements new regulations for adult-use of marijuana.




Future Farm Partners with Israeli Company to Develop Elite Cannabis Clones -- CFN Media

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the need to develop a wide variety of standardized cannabis plants for a vast array of potential applications, and the efforts of Future Farm Technologies Inc. (CSE: FFT) (CNSX: FFT) (CN.FFT) (OTCQB: FFRMF) to solve the problem.




Intelligent Highway Solutions, Inc. Issues Shareholder Update

Thu, 16 Nov 2017 18:30:59 EST

SACRAMENTO, CA--(Marketwired - Nov 16, 2017) - Intelligent Highway Solutions, Inc. (OTCBB: IHSI), today updates shareholders on the status of your Company.




Cosmos Holdings, Inc. Announces $3 Million Securities Purchase Agreement With Two Institutional Investors

Thu, 16 Nov 2017 14:01:17 EST

CHICAGO, IL--(Marketwired - Nov 16, 2017) - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors.




The Sequoia Project's Annual Meeting to Draw Health IT Leaders Nationwide to Discuss Data Sharing Progress and the Path Forward

Thu, 16 Nov 2017 09:28:07 EST

Event to be held December 5-6 in Gaylord National Harbor, Maryland




SANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care

Thu, 16 Nov 2017 09:00:00 EST

SUWANEE, GA--(Marketwired - Nov 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned Clinical and Science Symposium on Advanced Wound Care to be held on December 8 and 9, 2017, in Atlanta, GA. This event will gather SANUWAVE's clinical researchers, science advisors, Key Opinion Leaders, and world-wide distributors to discuss extracorporeal shockwave technology as an advanced modality in the wound care field, its current applications in the medical field, and future applications in wound care and other medical needs. Medical professionals and distributors will be attending from Taiwan, Italy, Brazil, and South Korea as well as medical advisors from the U.S. SANUWAVE is pleased to have among its presenters Dr. Maria Siemionow, Professor of Orthopedics and Director of Microsurgery Research at the University of Illinois at Chicago College of Medicine and Dr. Ching-Jen Wang, Professor of Orthopaedic Surgery at the Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Taiwan.




Cannabis Science Set to Launch its Online Community for Doctors, Patients, Industry Professionals Worldwide to Share Experiences and Expertise Using Cannabinoid Therapies for Various Critical Ailments, Palliative Care and Related Information

Thu, 16 Nov 2017 08:05:57 EST

IRVINE, CA--(Marketwired - Nov 16, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is proud to announce that next week the company will release its newest version of the Patient Access Center (PAC), an exclusive online community for social networking and information sharing platform. By bringing together Doctors, Patients, Industry Professionals, Lawyers, Scientists, Civil and Constitutional Rights Activists, Legalization Efforts Groups and many others, we are building a powerful knowledge center of real world data of successful treatment stories, formal clinical study information, to mobilizing large groups for upcoming events, or certain demographics that need help to help effective change for each area of concern or question.




BioCorRx Provides Business Update for the Third Quarter of 2017

Thu, 16 Nov 2017 08:00:00 EST

Investor Call to be held on Friday, November 17th at 2:00 PM ET




Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results

Thu, 16 Nov 2017 07:30:00 EST

VALENCIA, SPAIN--(Marketwired - Nov 16, 2017) - Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS CardiacT, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack), is pleased to announce that its MIDS Medical Limited joint venture ("MML") based at Sci-Tech, Daresbury (UK), has successfully completed initial testing of its "Hybrid Strip" system.




Angle PLC: Total Voting Rights and Covington Subscription

Thu, 16 Nov 2017 04:26:57 EST

GUILDFORD, SURREY--(Marketwired - Nov 16, 2017) - Angle PLC (OTCQX: ANPCY) (AIM: AGL)




Zecotek to Develop 3D Head-Up Display (HUD) with a Second Major Automobile Manufacturer

Wed, 15 Nov 2017 16:05:00 EST

SINGAPORE--(Marketwired - November 15, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS) (FRANKFURT: W1I) (OTC PINK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it is now working with a second major European automobile manufacturer to integrate its 3D technology into a brand specific 3D head-up display (HUD) for consumer use. On July 5, 2017, Zecotek announced that it had signed a joint development agreement with one of Europe's leading automobile companies. Zecotek's 3D HUD technology is attractive to leading auto manufactures because it is compact, does not require eye tracking and provides a deeper field of view than existing HUD displays as well as a platform for rich content.




Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

Wed, 15 Nov 2017 13:31:42 EST

LAS VEGAS, NV--(Marketwired - Nov 15, 2017) - Grey Cloak Tech Inc. (OTCQB: GRCK) today announces its purchase of the domain CBD.co. This announcement is made just as the Marijuana Business Conference (MJ BizCon) in Las Vegas is underway. Grey Cloak's vision for CBD.co is to make it a media destination and the primary marketplace for all types of hemp products, with the main focus on cannabidiol (CBD) products. 




mCig launches 420Cloud Desktop and 420Tienda Cannabis Super Site

Wed, 15 Nov 2017 09:20:27 EST

LAS VEGAS, NV--(Marketwired - Nov 15, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, announced today that the company expanded its technology offering with both the launch of the 420Tienda ecommerce platform and 420Cloud web edition.




GeoVax HIV Clinical Trials Update

Wed, 15 Nov 2017 09:00:00 EST

Participant Enrollment Completed for HVTN 114 Trial




Advanced Proteome Therapeutics Announces Formation of Business Advisory Committee

Wed, 15 Nov 2017 08:00:00 EST

VANCOUVER, BC--(Marketwired - November 15, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8), announced today that it has formed an Advisory Business Committee to assist in implementing the Company's current plans and identifying means to capitalize on future growth opportunities. The Committee will provide guidance with respect to the current business environment and will investigate and respond to questions from the board of directors and the management team of Advanced Proteome Therapeutics.




La sécurité des élèves sur le chemin de l'école : une responsabilité municipale

Wed, 15 Nov 2017 07:45:00 EST

MONTRÉAL, QUÉBEC--(Marketwired - 15 nov. 2017) - En cette journée d'ouverture du nouveau service d'injection supervisée (SIS) dans les locaux de Spectre de rue, les parents de l'école Marguerite-Bourgeoys assistés de Stéphanie Bellenger-Heng, commissaire scolaire de Ville-Marie (CSDM) réaffirment ce matin lors d'un point de presse sur le très fréquenté corridor scolaire, leur demandes d'accommodement horaire (de 9h30 à 14h30 afin d'éviter les horaires de circulation des enfants), assortie d'une consultation publique sur la plage horaire de 14h30 à 18h afin de recueillir les avis personnes et acteurs de proximité concernés, ainsi que l'ajout d'au moins un brigadier scolaire à l'intersection des rues De La Visitation et Ontario, pour assurer à la fois la sécurité des élèves à la fois qui y circulent le plus souvent seuls mais aussi celle de ceux qui attendent les bus pour rentrer à la maison.




Born on eCOA: The New Standards of Deployment, New Webinar Hosted by Xtalks

Wed, 15 Nov 2017 07:30:00 EST

TORONTO, ON--(Marketwired - November 15, 2017) - Validated instruments that measure patient symptoms, mental state and disease progression as clinical endpoints have traditionally been developed on paper. Increasing adoption of electronic clinical outcome assessments (eCOA) has resulted in a surge of legacy instrument migrations from paper to electronic formats. The process is time-intensive, requires multiple stakeholders and is often complex.




BioCorRx Enters Confidentiality Agreement with Federal Government Research Institute; Plans to Attend FDA Meeting for Naltrexone Implant

Wed, 15 Nov 2017 07:30:00 EST

ANAHEIM, CA--(Marketwired - Nov 15, 2017) - BioCorRx, Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addiction, today announced that it has entered into a confidentiality agreement with the National Institute on Drug Abuse (NIDA), a United States federal-government research institute whose mission is "to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health." The purpose of the agreement is to share confidential information and potentially collaborate on further research, development and commercialization of the Company's therapies and programs for opioid use disorder.




Naia Rare Diseases Announces Clinical Trial Authorisation (CTA) to Initiate Clinical Trials of NB 1001 for Short Bowel Syndrome in the United Kingdom

Wed, 15 Nov 2017 07:00:00 EST

RICHMOND, CA--(Marketwired - November 15, 2017) - Naia Rare Diseases, a biopharmaceutical company developing drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases today announced that it has received Clinical Trial Authorisation ("CTA") from the Medicine and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom to initiate a clinical trial of its long-acting GLP-1 agonist, NB 1001, in adult patients with SBS.




Breathtec Biomedical Unaware of Any Material Change

Tue, 14 Nov 2017 13:48:30 EST

VANCOUVER, BC--(Marketwired - Nov 14, 2017) - Breathtec Biomedical, Inc. (CSE: BTH) (OTCQB: BTHCF) (the "Company" or "Breathtec") - at the request of the Investment Industry Regulatory Organization of Canada, Breathtec has confirmed that its management is unaware of any material change in the operations of the Company that would account for the recent market activity. The Company will continue to provide updates of any material changes if and when they occur.




MediXall Group, Inc. Completes Milestones, Looks To Launch MediXaid Platform and Expand Sales & Marketing

Tue, 14 Nov 2017 11:36:19 EST

FT LAUDERDALE, FL--(Marketwired - Nov 14, 2017) - MediXall Group Inc. (OTCQB: MDXL) announced today that several significant milestones have been completed. The Company, which initially targeted the South Florida region, will be the first platform of its kind to address the need for consumer-facing healthcare technology and pricing transparency at a level that meets and exceeds regulatory and professional standards, while offering a familiar and convenient user experience, setting MediXaid.com apart from all others.




Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

Tue, 14 Nov 2017 11:07:15 EST

Record Total Revenue Reported, Led by Increases in Products & Services (+21%), Consumables (+158%), and Grant (+23%) Revenue (Y/Y); Investor Conference Call Scheduled for Tuesday, November 14, 2017 at 4:30 PM EDT




RJD Green, Inc. Updates Progression of Animal Waste Management and 2017 10K Filing

Tue, 14 Nov 2017 10:25:59 EST

TULSA, OK--(Marketwired - Nov 14, 2017) - RJD Green, Inc. (OTC PINK: RJDG), a three-division holding company focused on the health care services, environmental, and construction/industrial services segments, today announces the Animal Waste Management Division has completed the operating software platform necessary for computerized management of the patented waste to protein process. This allows RJD Green to move forward with capital procurement efforts to build and operate the first plant. Timing of funding efforts is scheduled post audit approval within the acquisition funding package.




Heritage Biologics Selects VUCA Health to Provide On-Demand, Prescription-Specific and Educational Videos to Customers

Tue, 14 Nov 2017 10:13:07 EST

LAKE MARY, FL--(Marketwired - Nov 14, 2017) - VUCA Health announced today that Heritage Biologics, a provider of preeminent value-based specialty pharmacy and high performance nursing services, will implement VUCA's educational and informational video library to enhance patient education and family engagement. In doing so, customers using Heritage Biologics' Pharmacy Patient Experience program (RXPX) will have access to a user-friendly platform containing on-demand, prescription-specific videos during in-home visits and through their individual patient portals.




LogicStream Health Moves Into New Office to Support Continued Rapid Growth

Tue, 14 Nov 2017 09:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Nov 14, 2017) - LogicStream Health, Inc. announced today that in the wake of its rapid and consistent growth, the company has relocated to a larger office in downtown Minneapolis. Since 2015, LogicStream has doubled the size of its full-time clinical and technology staff positions to support the nearly 200 hospitals and 2,500 clinics that have implemented the LogicStream Platform to better control clinical processes and improve care delivery. The new office location, 110 North 5th Street, Suite 650, will allow the company to continue adding staff to support its expanding client base.




Pivot Pharma Focuses on Cannabinoid Delivery -- CFN Media

Tue, 14 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 14, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the need to improve the effectiveness of cannabinoid drug delivery and the efforts of Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) to solve the problem.




Spectral Announces Third Quarter Results

Tue, 14 Nov 2017 08:00:00 EST

TORONTO, ONTARIO--(Marketwired - Nov. 14, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today announced its unaudited financial results for the third quarter ended September 30, 2017.




Endexx Lands Award for Best Advancements in Hemp Industry at Uptick Newswire's Uppie Awards

Tue, 14 Nov 2017 08:00:00 EST

CAVE CREEK, AZ--(Marketwired - Nov 14, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient based food and nutritional products, is pleased to announce that it has been awarded "Best Advancements in the Hemp Industry" at Uptick Newswire's Uppie Awards. The Uppie Awards honor companies in the Technology, Medical, Bio-Tech, Pharma, Energy, and Cannabis categories.




The Pharma Life Cycle: Plagued with Integration and Data Management Challenges, or Opportunities?

Tue, 14 Nov 2017 07:30:00 EST

TORONTO, ON--(Marketwired - November 14, 2017) - In a complementary webinar hosted by Xtalks, industry expert Gary Palgon, Vice President of Healthcare and Life Sciences Solutions at Liaison Technologies will discuss how to manage and successfully integrate the complex data streams involved with the pharma life cycle. The live event takes place on Thursday, November 30, 2017 at 2pm EST.




Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2017

Tue, 14 Nov 2017 07:00:00 EST

HOUSTON, TX--(Marketwired - November 14, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced its financial results for the third quarter ended September 30, 2017. Additionally, the Company announced potential upcoming milestones and recent corporate developments.




eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American Heart Association

Mon, 13 Nov 2017 15:45:00 EST

Antithrombotic EP-7041 safe and well tolerated; performed in antithrombotic test range associated with clinical efficacy and with fast onset/offset of activity




Invitation/Point de presse : La sécurité des élèves sur le chemin de l'école, une responsabilité municipale

Mon, 13 Nov 2017 13:37:25 EST

MONTRÉAL, QUÉBEC--(Marketwired - 13 nov. 2017) - Vous êtes cordialement invités au point de presse « la sécurité des élèves sur le chemin de l'école : une responsabilité municipale. »

Date : le 15 novembre de 7h40 à 7h55 (avant l'entrée en classe des élèves de Marguerite-Bourgeoys)




Medifirst Solutions to Introduce the Time Machine Laser at the Greater New York Dental Meeting at the Javits Convention Center

Mon, 13 Nov 2017 13:29:15 EST

FREEHOLD, NJ--(Marketwired - Nov 13, 2017) - MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it is exhibiting at the Greater New York Dental Meeting, a six-day event being held from November 24th to the 29th 2017 at the Jacob K. Javits Convention Center in New York City.




Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update

Mon, 13 Nov 2017 10:06:01 EST

SOUTH EASTON, MA--(Marketwired - Nov 13, 2017) -  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company's website). 




GeoVax to Present at the Third International Conference on Vaccines Research and Development

Mon, 13 Nov 2017 09:00:00 EST

Presentation to Focus on Development of Zika, Ebola and Lassa Fever Vaccines




ORYZON to present new preclinical data of ORY-2001 at the Neuroscience 2017 meeting organized by the Society for Neuroscience

Mon, 13 Nov 2017 08:59:29 EST

MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - November 13, 2017) -

  • ORY-2001 reduces aggression in animal models
  • The drug also reduces social withdrawal
  • ORY-2001 proposed to restore cognitive function and treat behavioral alterations frequently associated with Alzheimer's disease patients



BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

Mon, 13 Nov 2017 08:30:00 EST

FREDERICK, MD--(Marketwired - Nov 13, 2017) - BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. We are pleased to announce that PharmEvo, our distributor in Vietnam, is hosting an Electroceuticals symposium following a successful launch of their sales & marketing strategy. Additionally, PharmEvo is expanding their territory to cover Cambodia & The Maldives.




SANUWAVE Health to Hold Third Quarter 2017 Financial Results and Business Update Call on Tuesday, November 21, 2017

Mon, 13 Nov 2017 08:30:00 EST

SUWANEE, GA--(Marketwired - Nov 13, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2017 on November 14, 2017.




MCIG Takes Further Steps To Capitalize On The Lucrative Cannabis Opportunity In California City

Mon, 13 Nov 2017 07:00:00 EST

LAS VEGAS, NV--(Marketwired - Nov 13, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, announced today that the company has applied for a license for manufacturing medical cannabis in California City. MCIG currently has over 2 acres of land in escrow.